2005
DOI: 10.1158/0008-5472.can-04-1408
|View full text |Cite
|
Sign up to set email alerts
|

A Mouse Model of Human Breast Cancer Metastasis to Human Bone

Abstract: Currently, an in vivo model of human breast cancer metastasizing from the orthotopic site to bone does not exist, making it difficult to study the many steps of skeletal metastasis. Moreover, models used to identify the mechanisms by which breast cancer metastasizes to bone are limited to intracardiac injection, which seeds the cancer cells directly into the circulation, thus bypassing the early steps in the metastatic process. Such models do not reflect the full process of metastasis occurring in patients. We… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
175
2
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 179 publications
(185 citation statements)
references
References 23 publications
7
175
2
1
Order By: Relevance
“…In vivo models have been developed to study breast cancer metastases to bone by means of i.v. and skeletal injection of breast cancer cells in mice (13). Although in vivo models play an essential role in replicating physiological conditions, they lack the possibility to analyze highly specific interactions between human cancer cells, human blood vessels, and tissues, and they are not well suited to perform reproducible parametric studies.…”
mentioning
confidence: 99%
“…In vivo models have been developed to study breast cancer metastases to bone by means of i.v. and skeletal injection of breast cancer cells in mice (13). Although in vivo models play an essential role in replicating physiological conditions, they lack the possibility to analyze highly specific interactions between human cancer cells, human blood vessels, and tissues, and they are not well suited to perform reproducible parametric studies.…”
mentioning
confidence: 99%
“…32 Humanized murine models of prostate cancer bone metastases which seek to incorporate a humanized bone marrow niche such as with engineered bone scaffolds seeded with human BM-MSCs, or human fetal or hip bone grafts, or engraftment of human haematopoietic stem cells and BM-MSCs into a murine background may generate predictive preclinical models but these are cumbersome and difficult modeling strategies which are not yet well established. [33][34][35][36] One strategy to demonstrate proof-of-principle implicating a candidate seed-and-soil mechanism in prostate cancer is to use the "clinic as laboratory" model to circumvent the limitations of existing animal models. For example, an early phase clinical study with a potent neutralizing antibody to a5b1 designed with a primary pharmacodynamic endpoint of preferential mobilization of a5b1-expressing circulating tumor cells into the peripheral blood of men with bone-dominant metastases could permit evidence for the role of the a5b1pathway in mediating adhesive interactions of prostate cancer cells in the bone marrow.…”
Section: Discussionmentioning
confidence: 99%
“…The resultant light pink crude material was purified by flash column chromatography over silica gel with toluene:ether:acetic acid (63:35:2) to give a pale yellow oil (1.999 g, 91%). 1 676 g, 82%). Without further purification, the diamine (1.148 g, 7.16 mmol) was dissolved in 15 mL methanol:ethanol (2:3) and slowly added via addition funnel to a 15-mL solution of 2,4-pentadione (7.4 mL, 71.8 mmol) in methanol:ethanol (2:3) with vigorous stirring at 0°C.…”
Section: Methodsmentioning
confidence: 99%
“…This crude material was recrystalized in hot toluene to give a white crystalline solid (0.984 g, 42%). 1 [Co(III)(Heptanoic Acido)(Acacen)(NH 3)2] ؉ CH3COO ؊ [Co(III)-sb]. Cobalt acetate (0.182 g, 0.732 mmol) was dissolved in 5 mL methanol and filtered whereas compound 4 (0.238 g, 0.733 mmol) was dissolved separately in 5 mL methanol.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation